Table 1.
Clinical characteristics of patients with Parkinson’s disease (PD) before and after treatment.
| Before rehabilitation program | After rehabilitation program | P | |
|---|---|---|---|
| Number of participants | 39 | 39 | |
| Parkinson’s disease evaluation | |||
| Hoehn and Yahr | 2.4 ± 0.5 | 2.5 ± 0.5 | 0.40 |
| MDS-UPDRS-I | 9.04 ± 6.27 | 7.67 ± 5.99 | 0.46 |
| MDS-UPDRS-II | 9.44 ± 6.50 | 9.71 ± 8.35 | 0.54 |
| MDS-UPDRS-III | 26.71 ± 12.06 | 22.87 ± 15.39 | 0.30 |
| MDS-UPDRS-IV | 4.11 ± 3.66 | 4.24 ± 3.66 | 0.67 |
| Balance | |||
| Falls self-efficacy score | 26.87 ± 9.03 | 24.73 ± 7.86 | 0.05 |
| Mini Best test | 24.13 ± 3.12 | 24.73 ± 2.62 | 0.18 |
| Quality of life | |||
| EQ5D | 7.89 ± 1.42 | 7.59 ± 1.57 | 0.03 |
| EQ5D EVA | 65.78 ± 16.99 | 66.76 ± 15.56 | 0.57 |
| Psychological evaluation | |||
| Depression (BDI) | 11.53 ± 6.74 | 11.81 ± 8.43 | 0.91 |
| Anxiety (PAS) | 12.82 ± 7.16 | 12.84 ± 8.10 | 0.57 |
| Apathy (LARS) | −7.3 ± 4.6 | −9.0 ± 3.4 | 0.02 |
| 6-min test | |||
| Distance | 452.66 ± 75.39 | 470.29 ± 60.11 | 0.01 |
| Cadence (steps/min) | 118.01 ± 11.88 | 121.08 ± 10.13 | 0.01 |
| Velocity (m/s) | 1.28 ± 0.20 | 1.32 ± 0.17 | <0.01 |
| Stride length (m) | 1.29 ± 0.13 | 1.31 ± 0.15 | 0.04 |
| Asymmetry index (PCI, %) | 5.42 ± 2.28 | 5.41 ± 2.46 | 0.49 |
MDS-UPDRS: Movement Disorder Society-Unified Parkinson’s Disease Rating Scale, EQ5D: European Quality of life-5 Domains, BDI: Beck Depression Inventory, PSA: Parkinson Anxiety Scale, LARS: Lille Apathy Rating Scale, PCI: Phase Coordination Index.